DRIPBaR, a rapidly growing IV franchise in the US, has partnered with REVIV, a global leader in IV therapy, marking a significant milestone in the industry. With over 200 locations across 6 continents and plans for expansion, this collaboration aims to redefine industry standards and lead the next era of IV therapy.
DRIPBaR, with over 450 locations in the US, integrates REVIV X technology, enhancing its commitment to personalized nutrition solutions. Leveraging REVIV’s expertise and data-driven approach, DRIPBaR aims to revolutionize healthy lifestyles, offering tailored IV therapy to optimize health outcomes.
CEO of DRIPBaR, Ben Crosbie, highlights the strategic value of the partnership, expecting accelerated growth and industry leadership. Sarah Lomas, Founder and CEO of REVIV, underscores their shared commitment to innovation and safety, reshaping healthy living with personalized solutions.
This alliance signifies a transformative moment in the IV therapy industry, delivering safe and effective solutions to customers worldwide. As the IV market evolves, REVIV X emerges as the preferred solution, maintaining industry leadership and setting new standards for healthy lifestyle innovation.
About REVIV Global:
REVIV Global is a leading expert in IV therapy and personalized nutrition, with over 10 years of experience delivering safe and effective treatments worldwide. Their advanced precision health system utilizes biological and genomic data to provide personalized IV therapy solutions.
